{"entity":{"type":"insider","cik":"0001604572","url":"/insider/0001604572","json_url":"/insider/0001604572.json","name":"McClure Natalie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2014-12-03","last":"2016-04-20","span_basis":"filed_date"},"name_variants":[{"name":"McClure Natalie","source":"filing","n_filings":9,"first_seen":"2014-12-03","last_seen":"2016-04-20"}],"transactions":[{"id":3352715,"accession":"0001209191-16-115079","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-115079","line_url":"/filing/0001209191-16-115079","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":18.5,"price_display":"18.50","price_state":"stated","total_value":666000.0,"total_display":"666,000.00","total_whole":"666,000","shares_owned_after":8340.0,"shares_owned_after_display":"8,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-20","scope":"insider","n_lines":2},{"id":8674849,"accession":"0001209191-15-051512","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-051512","line_url":"/filing/0001209191-15-051512#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":18.95,"price_display":"18.95","price_state":"stated","total_value":37900.0,"total_display":"37,900.00","total_whole":"37,900","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-05","filed_date":"2015-06-09","scope":"insider"},{"id":8216825,"accession":"0001209191-15-040022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-040022","line_url":"/filing/0001209191-15-040022#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.62,"price_display":"17.62","price_state":"stated","total_value":35240.0,"total_display":"35,240.00","total_whole":"35,240","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-05","filed_date":"2015-05-07","scope":"insider"},{"id":8082220,"accession":"0001209191-15-032907","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-032907","line_url":"/filing/0001209191-15-032907#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.44,"price_display":"17.44","price_state":"stated","total_value":34880.0,"total_display":"34,880.00","total_whole":"34,880","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-06","filed_date":"2015-04-07","scope":"insider"},{"id":8598099,"accession":"0001209191-15-024190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-024190","line_url":"/filing/0001209191-15-024190#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.15,"price_display":"17.15","price_state":"stated","total_value":34300.0,"total_display":"34,300.00","total_whole":"34,300","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-09","scope":"insider"},{"id":8864522,"accession":"0001209191-15-010436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-010436","line_url":"/filing/0001209191-15-010436#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":16.87,"price_display":"16.87","price_state":"stated","total_value":33740.0,"total_display":"33,740.00","total_whole":"33,740","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-05","filed_date":"2015-02-06","scope":"insider"},{"id":8456345,"accession":"0001209191-15-002961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-002961","line_url":"/filing/0001209191-15-002961#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.59,"price_display":"17.59","price_state":"stated","total_value":35180.0,"total_display":"35,180.00","total_whole":"35,180","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-07","scope":"insider"},{"id":6206812,"accession":"0001209191-14-073973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-073973","line_url":"/filing/0001209191-14-073973#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":14.014,"price_display":"14.01","price_state":"stated","total_value":28028.0,"total_display":"28,028.00","total_whole":"28,028","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-05","filed_date":"2014-12-09","scope":"insider"},{"id":6709833,"accession":"0001209191-14-072896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-072896","line_url":"/filing/0001209191-14-072896#line-2","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604572","owner_name":"McClure Natalie","owner_display_name":"McClure Natalie","owner_url":"/insider/0001604572","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.5,"price_display":"14.50","price_state":"stated","total_value":290000.0,"total_display":"290,000.00","total_whole":"290,000","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001328143","name":"Adamas Pharmaceuticals Inc","url":"/issuer/0001328143","role":"Officer (SVP, Product Development)","n_filings":9,"first_seen":"2014-12-03","last_seen":"2016-04-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604572","retrieved_at":"2026-08-22T09:25:11+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}